Volume 62, Issue 3, Pages (September 2002)

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Prevalence and Distribution of Sub-Clinical Atherosclerosis by Screening Vascular Ultrasound in Low and Intermediate Risk Adults: The New York Physicians.

Andrew Moran, MD, MPH, Ronit Katz, PhD, Nicolas L. Smith, PhD, Linda F

Reduced renal function in patients with simple renal cysts

Volume 66, Issue 6, Pages (December 2004)

Volume 54, Issue 2, Pages (August 1998)

Diagnosis and Management of Chronic Kidney Disease

Volume 65, Issue 5, Pages (May 2004)

Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R.

Volume 72, Issue 5, Pages (September 2007)

Subclinical rejection in renal transplants is associated with low serum mannose-binding lectin levels Meritxell Ibernon, Francesc Moreso, Daniel Serón

Volume 61, Issue 4, Pages (April 2002)

Volume 57, Issue 5, Pages (May 2000)

Screening early renal failure: Cut-off values for serum creatinine as an indicator of renal impairment Cécile Couchoud, Nicole Pozet, Michel Labeeuw,

John P. Middleton, Patrick H. Pun Kidney International

Cystatin-C and inflammatory markers in the ambulatory elderly

Higher systolic blood pressure is associated with progression of carotid intima–media thickness in patients with chronic kidney disease Jessica Kendrick,

Volume 64, Issue 2, Pages (August 2003)

Homocysteine and risk in end-stage renal disease: a matter of context

How to interpret the eGFR in patients with small body surface area

Anemia as a risk factor for chronic kidney disease

Comorbidity and confounding in end-stage renal disease

Dietary phosphorus is associated with greater left ventricular mass

Volume 66, Issue 3, Pages (September 2004)

Volume 70, Issue 11, Pages (December 2006)

Volume 88, Issue 5, Pages (November 2015)

Volume 56, Issue 3, Pages (September 1999)

Volume 64, Issue 1, Pages (July 2003)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Volume 71, Issue 6, Pages (March 2007)

Volume 65, Issue 2, Pages (February 2004)

Volume 70, Issue 12, Pages (December 2006)

Anemia as a risk factor for cardiovascular disease

Volume 66, Issue 3, Pages (September 2004)

Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease Joan C. Lo, Glenn M. Chertow, Alan S. Go, Chi-Yuan.

Amit X. Garg, William F. Clark, R. Brian Haynes, Andrew A. House

Fructose intake as a risk factor for kidney stone disease

Volume 68, Pages S4-S10 (August 2005)

Predicting acute renal failure after coronary bypass surgery: Cross-validation of two risk- stratification algorithms Elizabeth Bowen Fortescue, David.

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

Reduced renal function in patients with simple renal cysts

Counteracting progression of renal disease: A look into the future

The global challenge of chronic kidney disease

Volume 73, Issue 7, Pages (April 2008)

Lynda Anne Szczech, Ira L. Lazar Kidney International

Unilateral renal cystic disease

Volume 58, Issue 3, Pages (September 2000)

Terry Behrend, Steven B. Miller, M.D Kidney International

A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related.

Volume 74, Issue 5, Pages (September 2008)

Homocysteine, renal function, and risk of cardiovascular disease

Volume 70, Issue 3, Pages (August 2006)

Volume 64, Issue 2, Pages (August 2003)

Volume 74, Issue 9, Pages (November 2008)

The Danish Renal Biopsy Register

Volume 80, Issue 10, Pages (November 2011)

Pathophysiology of cardiovascular disease in hemodialysis patients

Is complement a target for therapy in renal disease?

Volume 59, Issue 5, Pages (May 2001)

H.J. Chin, H. Ro, H.J. Lee, K.Y. Na, D.-W. Chae Kidney International

James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon

Volume 64, Issue 4, Pages (October 2003)

Volume 78, Issue 5, Pages (September 2010)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Volume 66, Issue 6, Pages (December 2004)

Volume 58, Issue 3, Pages (September 2000)

Presentation transcript:

Volume 62, Issue 3, Pages 997-1004 (September 2002) Cardiovascular disease risk status in elderly persons with renal insufficiency Michael G. Shlipak, Linda F. Fried, Casey Crump, Anthony J. Bleyer, Teri A. Manolio, Russell P. Tracy, Curt D. Furberg, Bruce M. Psaty Kidney International Volume 62, Issue 3, Pages 997-1004 (September 2002) DOI: 10.1046/j.1523-1755.2002.00522.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Distribution of serum creatinine levels among Cardiovascular Health Study (CHS) participants, stratified by gender (N = 5808). Symbols are: () women; (▪) men. Kidney International 2002 62, 997-1004DOI: (10.1046/j.1523-1755.2002.00522.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Distribution of serum creatinine levels among Cardiovascular Health Study (CHS) participants, stratified by gender (N = 5808). Symbols are: () women; (▪) men. Kidney International 2002 62, 997-1004DOI: (10.1046/j.1523-1755.2002.00522.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Disease prevalence by estimated creatinine clearance. (N = 145 for ‘<30’; 423 for ‘30-39’; 1051 for ‘40-49’; 1426 for ‘50-59’; 1354 for ‘60-69’; 769 for ‘70-79’; and 622 for ‘≥80’ mL/min/1.73 m2). Clinical disease (▪) includes CHD and stroke; subclinical disease () includes ankle-arm index <0.9, common carotid IMT in upper quintile, left ventricular hypertrophy, and abnormal/borderline left ventricular ejection fraction. P value for linear trend <0.001 for both clinical and subclinical disease. Kidney International 2002 62, 997-1004DOI: (10.1046/j.1523-1755.2002.00522.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Disease prevalence by estimated creatinine clearance. (N = 145 for ‘<30’; 423 for ‘30-39’; 1051 for ‘40-49’; 1426 for ‘50-59’; 1354 for ‘60-69’; 769 for ‘70-79’; and 622 for ‘≥80’ mL/min/1.73 m2). Clinical disease (▪) includes CHD and stroke; subclinical disease () includes ankle-arm index <0.9, common carotid IMT in upper quintile, left ventricular hypertrophy, and abnormal/borderline left ventricular ejection fraction. P value for linear trend <0.001 for both clinical and subclinical disease. Kidney International 2002 62, 997-1004DOI: (10.1046/j.1523-1755.2002.00522.x) Copyright © 2002 International Society of Nephrology Terms and Conditions